Jerusalem Global Ventures

About

Portfolio · 17

Quiet Therapeutics

Anticancer Therapeutics Using Nanoparticles and Biomarkers

1 round $12.0M committed Latest: 2015-04

SolarEdge Technologies

Renewable Energy Semiconductor Manufacturing

1 round $24.0M committed Latest: 2015-01

Moovit

Live Transport App with Maps

1 round $50.0M committed Latest: 2015-01

Altair Semiconductor

Single-mode LTE Telecom Chipsets

1 round $25.0M committed Latest: 2014-06

Wilocity

Wireless Chipsets for the Notebook and Peripheral Markets

Led ★ 2 rounds $55.0M committed Latest: 2013-10

MacroCure

Therapeutic Platform for Hard-to-Heal Wounds

1 round $35.0M committed Latest: 2012-05

StorONE

Large-scale Storage System

1 round $20.0M committed Latest: 2012-03

Powermat Technologies

Wireless Charging Solutions

1 round $80.0M committed Latest: 2011-10

Face.com

Facial Recognition Technologies

1 round $5.8M committed Latest: 2010-10

Camero

Radar-based Imaging Systems

3 rounds $24.5M committed Latest: 2009-08

Chiasma

Oral Therapeutic Options for Patients with Rare Diseases

1 round $7.7M committed Latest: 2005-09

Lumus

Lightweight AR Eyewear

1 round $6.0M committed Latest: 2005-01

Mellanox Technologies

Server Farm Connectivity and Storage Solutions

1 round $56.0M committed Latest: 2002-02

PowerDsine

Power over Ethernet Solutions

1 round Latest: 2002-02

Notal Vision

Remote Patient Monitoring for Retinal Diseases

1 round Latest: 2001-05

Oridion

Capnography Systems for Critical Care

1 round $15.0M committed Latest: 1997-08

Galileo Technology

Fabless Semiconductors

1 round $4.5M committed Latest: 1994-08

Investment activity

10 portfolio exits on record.

Q&A

What is Jerusalem Global Ventures' most recent exit?

Jerusalem Global Ventures' most recent exit was Altair Semiconductor, which was acquired by Sony Corporation for $212M in January 2016.

Which public exits has Jerusalem Global Ventures had?

Jerusalem Global Ventures has had several public exits, including Chiasma, which went public on NASDAQ in July 2015 with a valuation of $562M, and SolarEdge Technologies, which went public on NASDAQ in March 2015 with a valuation of $685M.

What is Jerusalem Global Ventures' focus in terms of investment stages?

Jerusalem Global Ventures invests across various stages, including B, C, D, E, F, and G Rounds. Their Tamar Fund specifically focuses on the early-growth stage of category-leading technology companies.

Who are the managing partners at Jerusalem Global Ventures?

Shlomo Kalish serves as a Managing Partner at Jerusalem Global Ventures.

What is Jerusalem Global Ventures' geographic focus?

Jerusalem Global Ventures invests in Israeli and Israel-related technology start-ups.

Which sectors does Jerusalem Global Ventures primarily invest in?

Jerusalem Global Ventures shows a concentration in Industrial Technologies and Health Tech & Life Sciences, with 5 and 4 portfolio companies respectively in these sectors.

Can you name some of Jerusalem Global Ventures' portfolio companies?

Jerusalem Global Ventures' portfolio includes companies such as Lumus, which develops lightweight AR eyewear, and Notal Vision, focused on remote patient monitoring for retinal diseases.

What was a significant acquisition exit for Jerusalem Global Ventures prior to 2016?

In July 2014, Wilocity, a Jerusalem Global Ventures portfolio company, was acquired by Qualcomm for $300M.